NU-DERM SYSTEM NORMAL-OILY

Product NDC: 62032-513
11-digit product format: 620320513
Labeler code: 62032
Product ID: 62032-513_76204b7d-f856-4aa7-91d3-a04432eb9254
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Hydroquinone, Octinoxate, and Zinc Oxide
Dosage form: KIT
Labeler: OMP, INC.
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2012-11-07
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	62032-513		I	Inactivated by FDA		2026-10-05
excluded package	package	62032-513	62032-513-00	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62032-513-00	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62032-513-00	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62032-513-00	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62032-513-00	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62032-513-00	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62032-513-00	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62032-513-00	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62032-513-00	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62032-513-00	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62032-513-00	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62032-513-00	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62032-513-00	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	62032-513-00	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	62032-513-00	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	62032-513-00	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	62032-513-00	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	62032-513-00	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	62032-513-00	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	62032-513-00	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	62032-513-00	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	62032-513-00	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	62032-513-00	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
85490a6b-2306-6bf2-c51b-eb63537dc2da	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-513-00	2020-01-31	C162847	48780-1	9d75b9d0-3c2b-f424-e053-dadaa90a57ce	NU-DERM ® SYSTEM NORMAL-OILY SKIN TRANSFORMATION KIT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-100-36	NU-DERM SYSTEM NORMAL-OILYSKIN TRANSFORMATION	57 g in 1 BOTTLE, PLASTIC	CREAM	57 g	40 mg in 1g	1
62032-101-36	NU-DERM SYSTEM NORMAL-OILYSKIN TRANSFORMATION	57 g in 1 BOTTLE, PLASTIC	CREAM	57 g	40 mg in 1g	1
62032-104-90	NU-DERM SYSTEM NORMAL-OILYSKIN TRANSFORMATION	85 g in 1 TUBE	LOTION	85 g	75 mg in 1g	1
62032-513-00	NU-DERM SYSTEM NORMAL-OILYSKIN TRANSFORMATION	1 in 1 CARTON	KIT	1		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HYDROQUINONE	ACTIVE INGREDIENT	XV74C1N1AE	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROQUINONE	ACTIVE MOIETY	XV74C1N1AE	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
1,2-HEXANEDIOL	INACTIVE INGREDIENT	TR046Y3K1G	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CHLORPHENESIN	INACTIVE INGREDIENT	I670DAL4SZ	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROGENATED PALM GLYCERIDES	INACTIVE INGREDIENT	YCZ8EM144Q	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)	INACTIVE INGREDIENT	86FQE96TZ4	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLISOTHIAZOLINONE	INACTIVE INGREDIENT	229D0E1QFA	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-10 DIMETHICONE (600 CST)	INACTIVE INGREDIENT	8PR7V1SVM0	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PEG-40 STEARATE	INACTIVE INGREDIENT	ECU18C66Q7	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PENTYLENE GLYCOL	INACTIVE INGREDIENT	50C1307PZG	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PHENYL TRIMETHICONE	INACTIVE INGREDIENT	DR0K5NOJ4R	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYOXYL 20 CETOSTEARYL ETHER	INACTIVE INGREDIENT	YRC528SWUY	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PPG-2 MYRISTYL ETHER PROPIONATE	INACTIVE INGREDIENT	88R97D8U8A	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM DIHYDROXYCETYL PHOSPHATE	INACTIVE INGREDIENT	YWI33EV595	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
SODIUM METABISULFITE	INACTIVE INGREDIENT	4VON5FNS3C	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
SQUALANE	INACTIVE INGREDIENT	GW89575KF9	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
TETRAHEXYLDECYL ASCORBATE	INACTIVE INGREDIENT	9LBV3F07AZ	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
TROLAMINE SALICYLATE	INACTIVE INGREDIENT	H8O4040BHD	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
TROPOLONE	INACTIVE INGREDIENT	7L6DL16P1T	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
UBIDECARENONE	INACTIVE INGREDIENT	EJ27X76M46	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-513	NU-DERM SYSTEM NORMAL-OILY SKIN TRANSFORMATION ( HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE) KIT [OMP, INC.]	1	Legacy NDC, 4 package rows	20130112_945ddb26-75b4-4f7c-94f2-7d8047cd3c51.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197795	hydroquinone 4 % Topical Cream	PSN	945ddb26-75b4-4f7c-94f2-7d8047cd3c51	1
197795	hydroquinone 40 MG/ML Topical Cream	SCD	945ddb26-75b4-4f7c-94f2-7d8047cd3c51	1
197795	hydroquinone 4 % Topical Cream	SY	945ddb26-75b4-4f7c-94f2-7d8047cd3c51	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
62032-100-36	62032010036	57 g in 1 BOTTLE, PLASTIC	57 g	Historical
62032-101-36	62032010136	57 g in 1 BOTTLE, PLASTIC	57 g	Historical
62032-104-90	62032010490	85 g in 1 TUBE	85 g	Historical
62032-513-00	62032051300	1 in 1 CARTON		Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
NU-DERM ® SYSTEM NORMAL-OILY SKIN TRANSFORMATION KIT	OMP, INC. \| MILBAR LABORATORIES \| PURETEK CORPORATION \| Ei INC. \| G.S. COSMECEUTICAL USA, INC. \| Bay Cities Container Corporation	2012-12-28	HUMAN PRESCRIPTION DRUG LABEL	1